PET123 Antibody

What is PET123 and what is its biological function?

PET123 is a small-subunit ribosomal protein found in yeast mitochondria that plays a crucial role in mitochondrial translation. Research has demonstrated that PET123 function is required for the translation of all mitochondrial gene products . The protein was identified through genetic studies where mutations in the nuclear gene PET123 were found to suppress mutations in PET122, which is a position activator required for cytochrome c oxidase subunit III (coxIII) translation . This genetic interaction provides important insights into the complex machinery of mitochondrial translation.

Functionally, PET123 appears to be present at levels comparable to other mitochondrial ribosomal proteins, and its accumulation depends on the presence of the 15S rRNA gene in mitochondria . This dependency highlights its integral role in ribosomal structure and function.

What types of PET123 antibodies are available for research?

Based on standard antibody development approaches, PET123 antibodies typically come in two main forms:

• Polyclonal antibodies: Generated by immunizing animals (commonly rabbits) with purified PET123 protein or peptide fragments. These recognize multiple epitopes on the PET123 protein.

• Monoclonal antibodies: Produced from single B-cell clones, providing high specificity to particular epitopes on PET123.

Similar to other mitochondrial protein antibodies, validation typically involves demonstrating specificity through detection of a single band of appropriate molecular weight in wild-type samples and absence of signal in PET123 knockout strains .

What research applications are PET123 antibodies suited for?

PET123 antibodies have been successfully employed in several research applications:

Research has demonstrated that antibodies against PET123 can be valuable tools for studying mitochondrial ribosome assembly and function, as they've been used to show that PET123 is indeed a mitochondrial ribosomal protein of the small subunit .

How should researchers validate the specificity of PET123 antibodies?

Proper validation of PET123 antibodies is crucial for reliable research results. A comprehensive validation approach should include:

• Western blot analysis: Confirm a single band of the expected molecular weight in wild-type samples and absence of this band in PET123 knockout or knockdown samples.

• Immunoprecipitation followed by mass spectrometry: This approach can verify that the antibody pulls down authentic PET123 protein.

• Immunostaining controls: Compare staining patterns between wild-type and knockout samples, or between samples with and without primary antibody.

• Pre-absorption test: Pre-incubate the antibody with purified PET123 protein before immunostaining to demonstrate specificity through signal reduction.

Researchers have successfully validated PET123 antibodies by demonstrating that the protein accumulation depends on the presence of the 15S rRNA gene in mitochondria, confirming its association with the mitochondrial ribosome .

What are the optimal conditions for immunoprecipitation using PET123 antibodies?

When performing immunoprecipitation with PET123 antibodies, researchers should consider the following protocol optimization:

• Lysis buffer composition: Use buffers containing mild detergents (0.5-1% NP-40 or Triton X-100) that preserve protein-protein interactions while effectively solubilizing mitochondrial membranes.

• Salt concentration: Typically, 150mM NaCl is suitable for maintaining physiological interactions, but salt concentration may need adjustment depending on the strength of the interactions being studied.

• Antibody coupling: For better results, covalently coupling the antibody to beads (protein A/G or directly to activated resin) can reduce background and prevent antibody co-elution.

• Elution conditions: Gentle elution using peptide competition or pH shift rather than boiling in SDS sample buffer may better preserve interacting partners for downstream analysis.

• Controls: Include IgG control immunoprecipitations and, where possible, immunoprecipitations from PET123-deficient samples.

In studies of yeast PET123, researchers have successfully used antibodies against PET123 to demonstrate its association with mitochondrial ribosomes, confirming its role and presence in the small ribosomal subunit .

What optimization is required for detecting PET123 in immunohistochemistry?

Optimizing immunohistochemistry protocols for PET123 detection requires attention to several key factors:

• Fixation: For mitochondrial proteins like PET123, paraformaldehyde (4%) fixation for 10-15 minutes typically preserves antigenicity while maintaining structural integrity.

• Antigen retrieval: Heat-induced epitope retrieval in citrate buffer (pH 6.0) or EDTA buffer (pH 8.0) may be necessary to expose epitopes masked during fixation.

• Permeabilization: Since PET123 is located within mitochondria, sufficient permeabilization is crucial. Use 0.1-0.3% Triton X-100 or 0.1% saponin to ensure antibody access to mitochondrial structures.

• Blocking: Extended blocking (1-2 hours) with 5-10% normal serum from the species of the secondary antibody plus 1% BSA helps reduce nonspecific binding.

• Primary antibody incubation: Overnight incubation at 4°C with optimized antibody dilution (typically 1:100 to 1:500) improves specific binding while reducing background.

Similar optimization approaches have been successful for other mitochondrial proteins, where researchers used primary antibodies at 1:500 dilution after heat-mediated antigen retrieval in citrate buffer .

How can PET123 antibodies be used to study mitochondrial translation defects?

PET123 antibodies are valuable tools for investigating mitochondrial translation defects through several approaches:

• Ribosome profiling with immunoprecipitation: PET123 antibodies can be used to isolate mitochondrial ribosomes followed by analysis of associated mRNAs, providing insights into translation defects at specific steps.

• Proximity labeling: By coupling PET123 antibodies with enzymes like BioID or APEX2, researchers can identify proteins that interact with PET123 in different translation states or disease conditions.

• Super-resolution microscopy: Advanced imaging using PET123 antibodies can reveal changes in ribosome distribution and clustering that may occur in translation-defective strains.

• Pulse-chase analysis: Combining PET123 immunoprecipitation with metabolic labeling allows tracking of nascent peptide synthesis rates and ribosome association.

Studies have established that mutations affecting the mRNA-specific translational activator PET122 can be suppressed by mutations in PET123, suggesting a functional interaction between these proteins in the translational machinery . This genetic relationship provides a foundation for using PET123 antibodies to investigate the molecular mechanisms underlying these genetic interactions.

What role might PET123 antibodies play in immuno-PET imaging applications?

While traditional PET123 antibodies are used for basic research, the principles of immuno-PET could potentially be applied to track mitochondrial biogenesis in living systems:

• Antibody modification: Similar to other immuno-PET applications, PET123 antibodies would need to be radiolabeled with appropriate isotopes such as 124I or 89Zr for PET imaging .

• Pharmacokinetic engineering: As with other immuno-PET applications, the clearance and tumor penetration characteristics of antibodies can be improved by using smaller antibody fragments like Fab, F(ab')2, or scFv, which allow imaging within 24 hours rather than the 4-7 days typically required for intact antibodies .

• Quantitative imaging: Immuno-PET has demonstrated utility in quantitatively measuring target expression, as shown with other antibodies where tumor uptake correlates linearly with antigen density (r2 = 0.75) .

• Detection sensitivity: Advanced immuno-PET techniques could potentially offer high sensitivity for detecting mitochondrial abnormalities, comparable to the 86% sensitivity reported for other immuno-PET applications compared to 76% for conventional imaging .

The principles demonstrated in clinical applications of immuno-PET, where radiolabeled antibodies have successfully detected metastases with tumor uptake 9.3-fold higher than in normal tissues , suggest potential for similar approaches with mitochondrial targets like PET123 in research settings.

How can computational approaches enhance PET123 antibody design?

Recent advances in computational antibody design can be applied to improve PET123 antibodies:

• Energy-based optimization: Modern computational approaches tackle antibody design as an optimization problem considering both structure rationality and functionality. For PET123 antibodies, this could mean optimizing binding energy while maintaining proper structural characteristics .

• Diffusion models: Pre-trained conditional diffusion models that jointly model sequences and structures with equivariant neural networks can guide the generation of antibodies with rational structures and considerable binding affinities to PET123 .

• Residue-level decomposed energy preference: Fine-tuning pre-trained diffusion models using residue-level decomposed energy preferences can optimize the energy of generated antibodies, potentially creating PET123 antibodies with higher specificity and affinity .

• Gradient surgery techniques: These computational methods address conflicts between various types of energy (attraction and repulsion) during antibody design, potentially resolving design challenges for complex targets like PET123 .

Studies have shown that these computational approaches can achieve state-of-the-art performance in designing high-quality antibodies with low total energy and high binding affinity simultaneously , suggesting their potential value for developing improved PET123 antibodies.

How is PET123 expression regulated at the post-transcriptional level?

Research has revealed important insights into the post-transcriptional regulation of PET123:

• Puf3-mediated regulation: PET123 mRNA appears to be regulated by Puf3, an RNA-binding protein that targets mRNAs encoding mitochondrial proteins. The Puf3-binding sites in the PET123 3'-UTR have an additive effect in conferring Puf3-dependent downregulation of PET123 mRNA .

• Casein Kinase I involvement: Casein Kinase I (specifically the isoform Hrr25 in yeast) appears to positively regulate mitochondrial biogenesis, potentially affecting PET123 expression .

• Translational control: The genetic interaction between PET123 and PET122 suggests a complex regulatory network controlling mitochondrial translation .

Understanding these regulatory mechanisms is crucial for interpreting antibody-based measurements of PET123 protein levels, as post-transcriptional regulation may lead to discrepancies between mRNA and protein abundance under different conditions.

What interactions between PET123 and other proteins can be studied using antibodies?

PET123 antibodies enable the investigation of several important protein interactions:

Research has established genetic interactions between PET123 and PET122, where mutations in PET123 can suppress mutations in PET122 . This suggests functional interactions between these proteins that could be further explored using antibody-based approaches. Additionally, the dependence of PET123 accumulation on the presence of the 15S rRNA gene indicates a structural relationship that could be studied using appropriate immunological techniques.

How can researchers troubleshoot weak or inconsistent signals with PET123 antibodies?

When facing weak or inconsistent signals, researchers should systematically evaluate:

• Antibody quality: Verify antibody functionality using positive control samples with known PET123 expression. Consider using antibodies that have been validated against recombinant proteins or knockout controls.

• Sample preparation: Ensure complete lysis of mitochondria, as incomplete disruption of mitochondrial membranes can limit antibody access to PET123. For yeast samples, methods like glass bead disruption may be necessary.

• Protein degradation: Add protease inhibitors immediately during sample preparation and maintain samples at cold temperatures throughout processing.

• Signal enhancement: For Western blotting, consider using high-sensitivity detection systems like ECL Plus or Femto. For immunostaining, tyramide signal amplification may improve detection.

• Epitope masking: If suspecting protein-protein interactions are blocking epitope recognition, consider mild denaturing conditions or epitope retrieval techniques.

Studies have shown that proper sample preparation is crucial for detecting mitochondrial ribosomal proteins, and researchers have successfully generated antibodies against PET123 that demonstrate its presence at levels comparable to other mitochondrial ribosomal proteins .

What controls are essential when working with PET123 antibodies?

Rigorous controls are essential for reliable results with PET123 antibodies:

• Positive controls: Include samples with known PET123 expression, such as wild-type yeast extracts where PET123 has been well-characterized .

• Negative controls: When possible, use pet123Δ mutant strains or other samples where PET123 is absent or depleted.

• Loading controls: For quantitative analysis, include controls for total protein loading (e.g., mitochondrial proteins like porin) and compartment-specific markers to normalize expression levels.

• Isotype controls: Include appropriate isotype control antibodies to distinguish specific from non-specific binding in immunoprecipitation and immunostaining experiments.

• Peptide competition: Pre-incubation of the antibody with excess PET123 peptide should abolish specific signals in all applications.

Researchers have used antibodies against PET123 to demonstrate that it is a mitochondrial ribosomal protein present at levels comparable to other ribosomal proteins, validating the specificity of their antibody through appropriate controls .